Patent · US Active

Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho

US8372952B2 · kind B2 · utility

31Cited by
71References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 1, 2010
Grant dateFeb 12, 2013
Priority date
Expiry dateDec 1, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/75
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Binding proteins that specifically bind to β-Klotho or portions thereof, FGFR1c or portions thereof, or both FGFR1c and β-Klotho, and optionally other proteins as well are provided. Coding sequences, methods of treatment and pharmaceutical compositions are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.